CIFALDI, LOREDANA CONCETTA
CIFALDI, LOREDANA CONCETTA
Dipartimento di Scienze cliniche e Medicina Traslazionale
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
2001-04-01 Cifaldi, L; Quaglino, E; Di Carlo, E; Musiani, P; Spadaro, M; Lollini, P; Wolf, S; Boggio, K; Forni, G; Cavallo, F
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
2013-02-01 Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, C; Locatelli, F; Gallo, A
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM
2008-05-01 Fontana, L; Fiori, M; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies
2024-01-01 Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB-neu T Mice
2024-01-01 Focaccetti, C; Nardozi, D; Benvenuto, M; Lucarini, V; Angiolini, V; Carrano, R; Scimeca, M; Servadei, F; Mauriello, A; Mancini, P; Mersini Besharat, Z; Milella, M; Migliaccio, S; Ferretti, E; Cifaldi, L; Masuelli, L; Palumbo, C; Bei, R
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective
2017-12-01 Cifaldi, L; Locatelli, F; Marasco, E; Moretta, L; Pistoia, V
CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses
2010-01-01 Carbone, T; Nasorri, F; Pennino, D; Eyerich, K; Foerster, S; Cifaldi, L; Traidl-Hoffman, C; Behrendt, H; Cavani, A
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
2020-11-01 Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D
Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission
2024-05-14 Pighi, C; Rotili, A; De Luca, M; Chiurchiù, S; Calò Carducci, Fi; Rossetti, C; Cifaldi, L; Bei, R; Caforio, L; Bernardi, S; Palma, P; Amodio, D
Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I
2009-02-01 Eyerich, K; Cifaldi, L; Notarangelo, L; Porta, F; Notarangelo, L; Mazzolari, E; Fiorini, M; Paradisi, A; Cavani, A
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
2022-01-01 Bei, R; Benvenuto, M; Focaccetti, C; Fazi, S; Moretti, M; Nardozi, D; Angiolini, V; Ciuffa, S; Cifaldi, L; Carrano, R; Palumbo, C; Miele, Mt; Bei, R; Barillari, G; Manzari, V; De Smaele, E; Modesti, A; Masuelli, L
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
2024-01-01 Ielpo, S; Barberini, F; Dabbagh Moghaddam, F; Pesce, S; Cencioni, C; Spallotta, F; De Ninno, A; Businaro, L; Marcenaro, E; Bei, R; Cifaldi, L; Barillari, G; Melaiu, O
Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma
2023-01-01 Benvenuto, M; Nardozi, D; Palumbo, C; Focaccetti, C; Carrano, R; Angiolini, V; Cifaldi, L; Lucarini, V; Mancini, P; Kerpi, B; Currenti, W; Bei, R; Masuelli, L
Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness
2024-02-21 Carrano, R; Grande, M; LETI MAGGIO, E; Zucca, C; Bei, R; Palumbo, C; Focaccetti, C; Nardozi, D; Lucarini, V; Angiolini, V; Mancini, P; Barberini, F; Barillari, G; Cifaldi, L; Masuelli, L; Benvenuto, M; Bei, R
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma
2023-02-02 Arena, A; Romeo Maria, A; Focaccetti, C; Anastasiadou, E; Trived, P; Cifaldi, Lc; Gilardini, M; Maria, S; Benedetti, R; Santarelli, R; Gonnella, R; Benvenuto, M; Marchese, C; Masuelli, L; Bei, R; Cirone, M
DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
2019-07-01 Cifaldi, L; Doria, M; Cotugno, N; Zicari, S; Cancrini, C; Palma, P; Rossi, P
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
2023-06-08 Cifaldi, L; Melaiu, O; Giovannoni, R; Benvenuto, M; Focaccetti, C; Nardozi, D; Barillari, G; Bei, R
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.
2022-07-28 Focaccetti, C; Benvenuto, M; Pighi, C; Vitelli, A; Napolitano, F; Cotugno, N; Fruci, D; Palma, P; Rossi, P; Bei, R; Cifaldi, L
Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
2020-06-01 Cifaldi, L; Di Santo, J; Olive, D
Endocrine-Disrupting Chemicals: Do Polyphenols Advantage or Counteract Their Activity?
2024-01-01 Benvenuto, M; Focaccetti, C; Cifaldi, L; Bei, R
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-apr-2001 | A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia | Cifaldi, L; Quaglino, E; Di Carlo, E; Musiani, P; Spadaro, M; Lollini, P; Wolf, S; Boggio, K; Forni, G; Cavallo, F | Articolo su rivista | |
| 1-feb-2013 | ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis | Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, C; Locatelli, F; Gallo, A | Articolo su rivista | |
| 1-mag-2008 | Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM | Fontana, L; Fiori, M; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D | Articolo su rivista | |
| 1-gen-2024 | Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies | Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G | Articolo su rivista | |
| 1-gen-2024 | Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB-neu T Mice | Focaccetti, C; Nardozi, D; Benvenuto, M; Lucarini, V; Angiolini, V; Carrano, R; Scimeca, M; Servadei, F; Mauriello, A; Mancini, P; Mersini Besharat, Z; Milella, M; Migliaccio, S; Ferretti, E; Cifaldi, L; Masuelli, L; Palumbo, C; Bei, R | Articolo su rivista | |
| 1-dic-2017 | Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective | Cifaldi, L; Locatelli, F; Marasco, E; Moretta, L; Pistoia, V | Articolo su rivista | |
| 1-gen-2010 | CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses | Carbone, T; Nasorri, F; Pennino, D; Eyerich, K; Foerster, S; Cifaldi, L; Traidl-Hoffman, C; Behrendt, H; Cavani, A | Articolo su rivista | |
| 1-nov-2020 | Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma | Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D | Articolo su rivista | |
| 14-mag-2024 | Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission | Pighi, C; Rotili, A; De Luca, M; Chiurchiù, S; Calò Carducci, Fi; Rossetti, C; Cifaldi, L; Bei, R; Caforio, L; Bernardi, S; Palma, P; Amodio, D | Articolo su rivista | |
| 1-feb-2009 | Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I | Eyerich, K; Cifaldi, L; Notarangelo, L; Porta, F; Notarangelo, L; Mazzolari, E; Fiorini, M; Paradisi, A; Cavani, A | Articolo su rivista | |
| 1-gen-2022 | Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo | Bei, R; Benvenuto, M; Focaccetti, C; Fazi, S; Moretti, M; Nardozi, D; Angiolini, V; Ciuffa, S; Cifaldi, L; Carrano, R; Palumbo, C; Miele, Mt; Bei, R; Barillari, G; Manzari, V; De Smaele, E; Modesti, A; Masuelli, L | Articolo su rivista | |
| 1-gen-2024 | Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy | Ielpo, S; Barberini, F; Dabbagh Moghaddam, F; Pesce, S; Cencioni, C; Spallotta, F; De Ninno, A; Businaro, L; Marcenaro, E; Bei, R; Cifaldi, L; Barillari, G; Melaiu, O | Articolo su rivista | |
| 1-gen-2023 | Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma | Benvenuto, M; Nardozi, D; Palumbo, C; Focaccetti, C; Carrano, R; Angiolini, V; Cifaldi, L; Lucarini, V; Mancini, P; Kerpi, B; Currenti, W; Bei, R; Masuelli, L | Articolo su rivista | |
| 21-feb-2024 | Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness | Carrano, R; Grande, M; LETI MAGGIO, E; Zucca, C; Bei, R; Palumbo, C; Focaccetti, C; Nardozi, D; Lucarini, V; Angiolini, V; Mancini, P; Barberini, F; Barillari, G; Cifaldi, L; Masuelli, L; Benvenuto, M; Bei, R | Articolo su rivista | |
| 2-feb-2023 | Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma | Arena, A; Romeo Maria, A; Focaccetti, C; Anastasiadou, E; Trived, P; Cifaldi, Lc; Gilardini, M; Maria, S; Benedetti, R; Santarelli, R; Gonnella, R; Benvenuto, M; Marchese, C; Masuelli, L; Bei, R; Cirone, M | Articolo su rivista | |
| 1-lug-2019 | DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? | Cifaldi, L; Doria, M; Cotugno, N; Zicari, S; Cancrini, C; Palma, P; Rossi, P | Articolo su rivista | |
| 8-giu-2023 | DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy | Cifaldi, L; Melaiu, O; Giovannoni, R; Benvenuto, M; Focaccetti, C; Nardozi, D; Barillari, G; Bei, R | Articolo su rivista | |
| 28-lug-2022 | DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. | Focaccetti, C; Benvenuto, M; Pighi, C; Vitelli, A; Napolitano, F; Cotugno, N; Fruci, D; Palma, P; Rossi, P; Bei, R; Cifaldi, L | Articolo su rivista | |
| 1-giu-2020 | Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer | Cifaldi, L; Di Santo, J; Olive, D | Articolo su rivista | |
| 1-gen-2024 | Endocrine-Disrupting Chemicals: Do Polyphenols Advantage or Counteract Their Activity? | Benvenuto, M; Focaccetti, C; Cifaldi, L; Bei, R | Articolo su rivista |